CR:DOI:7254dfd1e81a7ea8486654594db40a33
From IDWiki
{{#scite:
|reference=sehgal2022ef
|type=journal-article
|title=Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India
|author=Inderpaul S Sehgal;Sahajal Dhooria;Valliappan Muthu;Kuruswamy T Prasad;Ashutosh N Aggarwal;Arunaloke Chakrabarti;Hansraj Choudhary;Mandeep Garg;Ritesh Agarwal|+sep=;
|journal=The Lancet Infectious Diseases
|publisher=Elsevier BV
|year=2022
|doi=10.1016/s1473-3099(22)00057-3
|subject=Infectious Diseases
|issn=1473-3099
|retrieved-from=https://dx.doi.org/
|retrieved-on=2022-04-15
}}
